• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

我如何治疗镰状细胞病中的肾脏并发症。

How I treat renal complications in sickle cell disease.

机构信息

Department of Renal Medicine, King's College London, London, United Kingdom; Department of Renal Medicine, King's College Hospital NHS Foundation Trust, London, United Kingdom;

Division of Cancer Studies, Molecular Haematology, King's College London, London, United Kingdom; and Department of Haematological Medicine, King's College Hospital NHS Foundation Trust, London, United Kingdom.

出版信息

Blood. 2014 Jun 12;123(24):3720-6. doi: 10.1182/blood-2014-02-557439. Epub 2014 Apr 24.

DOI:10.1182/blood-2014-02-557439
PMID:24764565
Abstract

Renal disease is one of the most frequent and severe complications experienced by patients with sickle cell disease; its prevalence is likely to increase as the patient population ages. We recommend regular monitoring for early signs of renal involvement and a low threshold for the use of hydroxyurea as preventative measures for end-stage renal disease. Once renal complications are detected, a careful assessment of the patient is required to rule out other causes of renal disease. Proteinuria and hypertension should be managed aggressively and the patient referred to a specialist nephrology center when progressive decline in renal function is noted. For the few patients who develop advanced chronic kidney disease, timely planning for dialysis and transplantation can significantly improve outcome, and we recommend an exchange blood transfusion policy for all patients on the transplant waiting list and for those with a functioning graft. Alongside the invasive treatment regimes, it is important to remember that renal failure in conjunction with sickle cell disease does carry a significant burden of morbidity and that focusing on symptom control has to be central to good patient care.

摘要

肾脏疾病是镰状细胞病患者最常见和最严重的并发症之一;随着患者年龄的增长,其患病率可能会增加。我们建议定期监测肾脏受累的早期迹象,并将羟基脲作为预防终末期肾病的措施,及早使用。一旦发现肾脏并发症,需要仔细评估患者以排除其他肾脏疾病的原因。应积极治疗蛋白尿和高血压,并在肾功能进行性下降时将患者转介至专科肾脏病中心。对于少数出现晚期慢性肾脏病的患者,及时进行透析和移植规划可以显著改善预后,我们建议对所有移植等待名单上的患者和有功能移植物的患者实施输血交换政策。除了侵入性治疗方案外,还必须记住,镰状细胞病合并肾衰竭会带来重大的发病负担,因此关注症状控制必须是良好患者护理的核心。

相似文献

1
How I treat renal complications in sickle cell disease.我如何治疗镰状细胞病中的肾脏并发症。
Blood. 2014 Jun 12;123(24):3720-6. doi: 10.1182/blood-2014-02-557439. Epub 2014 Apr 24.
2
Renal complications of sickle cell disease: managing for optimal outcomes.镰状细胞病的肾脏并发症:为实现最佳结果进行管理。
Paediatr Drugs. 2002;4(1):29-36. doi: 10.2165/00128072-200204010-00004.
3
Outcomes following kidney transplantation in patients with sickle cell disease: The impact of automated exchange blood transfusion.镰状细胞病患者肾移植后的结局:自动换血输血的影响。
PLoS One. 2020 Aug 13;15(8):e0236998. doi: 10.1371/journal.pone.0236998. eCollection 2020.
4
Sickle cell nephropathy: an update on pathophysiology, diagnosis, and treatment.镰状细胞肾病:病理生理学、诊断及治疗的最新进展
Int Urol Nephrol. 2018 Jun;50(6):1075-1083. doi: 10.1007/s11255-018-1803-3. Epub 2018 Jan 30.
5
Liver Transplantation in Patients with Sickle Cell Disease in the United States.美国镰状细胞病患者的肝移植。
J Surg Res. 2020 Nov;255:23-32. doi: 10.1016/j.jss.2020.05.015. Epub 2020 Jun 12.
6
Interventions for chronic kidney disease in people with sickle cell disease.镰状细胞病患者慢性肾脏病的干预措施。
Cochrane Database Syst Rev. 2017 Jul 3;7(7):CD012380. doi: 10.1002/14651858.CD012380.pub2.
7
Interventions for chronic kidney disease in people with sickle cell disease.镰状细胞病患者慢性肾脏病的干预措施。
Cochrane Database Syst Rev. 2023 Aug 4;8(8):CD012380. doi: 10.1002/14651858.CD012380.pub3.
8
Recurrent sickle cell nephropathy in a transplanted kidney.移植肾中的复发性镰状细胞肾病
Am J Kidney Dis. 1987 Oct;10(4):306-13. doi: 10.1016/s0272-6386(87)80027-6.
9
Prevalence, treatment, and outcomes of renal conditions in pediatric sickle cell disease.小儿镰状细胞病肾脏疾病的患病率、治疗及转归
South Med J. 2011 Nov;104(11):752-6. doi: 10.1097/SMJ.0b013e318232d9ab.
10
An update on sickle cell nephropathy.镰状细胞肾病的最新进展。
Saudi J Kidney Dis Transpl. 2014 Mar;25(2):249-65. doi: 10.4103/1319-2442.128495.

引用本文的文献

1
The wider perspective: Barriers and recommendations for transfusion support for patients with sickle cell disease in low- and middle-income countries.更广阔的视角:低收入和中等收入国家镰状细胞病患者输血支持的障碍与建议
Br J Haematol. 2025 Jun;206(6):1585-1592. doi: 10.1111/bjh.20055. Epub 2025 Mar 27.
2
Selecting patients with sickle cell disease for gene addition or gene editing-based therapeutic approaches: Report on behalf of a joint EHA Specialized Working Group and EBMT Hemoglobinopathies Working Party consensus conference.为基于基因添加或基因编辑的治疗方法选择镰状细胞病患者:代表欧洲血液学协会(EHA)专门工作组和欧洲血液与骨髓移植协会(EBMT)血红蛋白病工作组联合共识会议撰写的报告
Hemasphere. 2025 Mar 13;9(3):e70089. doi: 10.1002/hem3.70089. eCollection 2025 Mar.
3
Early Detection of Renal Complication in Children With Sickle Cell Disease: A Single Center Prospective Study.镰状细胞病患儿肾脏并发症的早期检测:一项单中心前瞻性研究
Cureus. 2024 Jul 8;16(7):e64058. doi: 10.7759/cureus.64058. eCollection 2024 Jul.
4
Intravenous Hydration and Associated Outcomes in Patients With Sickle Cell Disease Admitted With Vaso-Occlusive Crises: A Systematic Review.镰状细胞病伴血管闭塞性危象入院患者的静脉补液及相关结局:一项系统评价
Cureus. 2024 Feb 19;16(2):e54463. doi: 10.7759/cureus.54463. eCollection 2024 Feb.
5
Renal outcomes in pediatric patients with sickle cell disease: a single center experience in Saudi Arabia.镰状细胞病儿科患者的肾脏结局:沙特阿拉伯的单中心经验。
Front Pediatr. 2023 Dec 15;11:1295883. doi: 10.3389/fped.2023.1295883. eCollection 2023.
6
Disease severity and renal function among sickle cell anaemia patients in a tertiary hospital, South-south, Nigeria: a cross sectional study.尼日利亚南南地区一家三级医院镰状细胞贫血患者的疾病严重程度和肾功能:一项横断面研究。
Malawi Med J. 2023 Mar;35(1):9-14. doi: 10.4314/mmj.v35i1.3.
7
Euvolemic automated transfusion to treat severe anemia in sickle cell disease patients at risk of circulatory overload.Euvolemic 自动输血治疗镰状细胞病患者伴循环超负荷风险的严重贫血。
Transfusion. 2024 Jan;64(1):124-131. doi: 10.1111/trf.17613. Epub 2023 Dec 8.
8
Nephrological Complications in Hemoglobinopathies: SITE Good Practice.血红蛋白病的肾脏并发症:SITE良好实践
J Clin Med. 2023 Dec 2;12(23):7476. doi: 10.3390/jcm12237476.
9
Interventions for chronic kidney disease in people with sickle cell disease.镰状细胞病患者慢性肾脏病的干预措施。
Cochrane Database Syst Rev. 2023 Aug 4;8(8):CD012380. doi: 10.1002/14651858.CD012380.pub3.
10
In Humanized Sickle Cell Mice, Imatinib Protects Against Sickle Cell-Related Injury.在人源化镰状细胞小鼠中,伊马替尼可预防镰状细胞相关损伤。
Hemasphere. 2023 Feb 28;7(3):e848. doi: 10.1097/HS9.0000000000000848. eCollection 2023 Mar.